SCHEMBL410434

SCHEMBL410434

O=C1CCC(=O)N1c1ccc2ncsc2c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 4/20 0.45
NPC1 O15118 2/20 0.45
RAB9A P51151 2/20 0.45
TDP1 Q9NUW8 2/20 0.45
KDM4E B2RXH2 1/20 0.45
HKDC1 Q2TB90 1/20 0.45
DYRK1A Q13627 5/20 0.44
DYRK1B Q9Y463 4/20 0.44
DYRK2 Q92630 3/20 0.44
LMNA P02545 2/20 0.43
CYP3A4 P08684 1/20 0.43
GAA P10253 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
HTT P42858 1/20 0.43
ALDH1A1 P00352 3/20 0.41
POLB P06746 3/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
HPGD P15428 1/20 0.41
KMT2A Q03164 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3173640 0.82 TDP1 (0.46) L3MBTL1NPC1RAB9ATDP1KDM4E
SCHEMBL414418 0.82 LMNA (0.45) L3MBTL1NPC1RAB9ATDP1KDM4E
SCHEMBL409024 0.81 LMNA (0.44) L3MBTL1NPC1RAB9ATDP1KDM4E
SCHEMBL423755 0.79 ALDH1A1 (0.44) L3MBTL1NPC1RAB9ATDP1KDM4E
SCHEMBL3188991 0.78 KMT2A (0.54) L3MBTL1NPC1RAB9ATDP1KDM4E
SCHEMBL413327 0.78 L3MBTL1 (0.43) L3MBTL1NPC1RAB9ATDP1KDM4E
SCHEMBL21091414 0.76 GAA (0.57) L3MBTL1NPC1RAB9ATDP1KDM4E
SCHEMBL3201343 0.76 L3MBTL1 (0.50) L3MBTL1TDP1CYP3A4CYP2C19ALDH1A1
SCHEMBL3201325 0.76 L3MBTL1 (0.50) L3MBTL1TDP1CYP3A4CYP2C19ALDH1A1
SCHEMBL3180629 0.76 TSHR (0.53) NPC1RAB9AKDM4ELMNACYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2408769-A1 PYRIMIDINE DERIVATIVES USED AS ITK INHIBITORS Glaxo Group Limited (GB) 2012-01-25 EP disclosed
WO-2011110575-A1 DERIVATIVES OF 2-[2-(BENZO- OR PYRIDO-) THIAZOLYLAMINO]-6-AMINOPYRIDINE, USEFUL IN THE TREATMENT OF RESPIRATORIC, ALLERGIC OR INFLAMMATORY DISEASES GLAXO GROUP LIMITED (GB) 2011-09-15 WO disclosed
WO-2010106016-A1 PYRIMIDINE DERIVATIVES USED AS ITK INHIBITORS GLAXO GROUP LIMITED (GB) 2010-09-23 WO disclosed